aycan workstation with Imaging Biometrics plug-in featured in a study published in the American Journal of Neuroradiology
Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies
Rochester, New York, March 19, 2020.
Perfusion MR imaging measures of relative CBV can distinguish recurrent tumor from posttreatment radiation effects in high-grade gliomas. Currently, relative CBV measurement requires normalization based on user-defined reference tissues. A recently proposed method of relative CBV standardization eliminates the need for user input. This study compares the predictive performance of relative CBV standardization against relative CBV normalization for quantifying recurrent tumor burden in high-grade gliomas relative to posttreatment radiation effects.
about aycan
With a focus on vendor-neutral integration and service, aycan is a leading global provider of solutions for viewing, printing, sharing, and storing medical images and information that improve workflow efficiency and drive down costs. aycan works with other industry innovators such as Apple and Xerox, whose quality products are part of their solutions. aycan supports worldwide customers with U.S. headquarters in Rochester, New York, and European headquarters in Wuerzburg, Germany. The company is privately held. www.aycan.com
aycan Media Contact
Dennis van Keken
(585) 473-1350
dvankeken@aycan.com